OrbiMed
-
With New $50 Million Infusion, West Chester’s Verrica Pharmaceuticals to Retire Debt
West Chester-based Verrica Pharmaceuticals has secured $50 million from a private stock sale, which will allow the company to retire its $35 million OrbiMed debt and finance future business activities,…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
